RO-7293583

DB17455InvestigationalProtein Based Therapies

RO-7293583 is a TYRP1-Targeting CD3 T-Cell Engager.

Mechanism: Pharmacologically active on T-cell surface glycoprotein CD3 and 5,6-dihydroxyindole-2-carboxylic acid oxidase
Curator reviewed
Code names: RG-6232 · RO-7293583

Resolves to

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with RO-7293583, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.